Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_2
2
40%
Ph phase_3
1
20%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Terminated(1)
Other(2)

Detailed Status

unknown2
Not yet recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

terminated120%
unknown240%
not_yet_recruiting240%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingphase_3

BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

NCT07678229
not_yet_recruitingphase_2

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

NCT07560826
unknown

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

NCT05899751
unknownnot_applicable

Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008

NCT01953770
terminatedphase_2

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

NCT02518750

Clinical Trials (5)

Showing 5 of 5 trials
NCT07678229Phase 3

BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

Not Yet Recruiting
NCT07560826Phase 2

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

Not Yet Recruiting
NCT05899751

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

Unknown
NCT01953770Not Applicable

Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008

Unknown
NCT02518750Phase 2

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Terminated

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5